Chase AIPricingFAQs
Display currency
Loading news…

C2i Genomics

New York, United States

C2i Genomics provides cloud-based cancer diagnostic services to pharmaceutical and diagnostic organizations.

C2i Genomics was acquired by Veracyte in 2026.
Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
20

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Company Info

Org types
company
HQ
New York, United States

Key People at C2i Genomics

Co-Founder, CEO
Board of Directors
Co-Founder & CTO
Scientific Co-Founder
20
professional contacts at C2i Genomics
Contact execs at C2i Genomics

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to C2i Genomics

Loading news…

FAQs about C2i Genomics

People who checked this page also checked these

Browse the full Acquirezy directory.
C2i Genomics - Company Profile, Full Acquisitions List, Funding and Investments